Conférence de Didier ROGNAN "Discovery of first-in-class extracellular FLT3 inhibitors for the treatment of neuropathic pain: From hits to a clinical candidate"

• Imprimer
• Partager

  Partager cette page

  • Facebook
  • Twitter
  • Linkedin
• Version PDF

Didier ROGNAN, Laboratoire d’Innovation Thérapeutique (LIT), UMR 7200, Université de Strasbourg BIODOL Therapeutics, Illkirch fera une conférence intitulée "Discovery of first-in-class extracellular FLT3 inhibitors for the treatment of neuropathic pain: From hits to a clinical candidate"